Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cognitive Effect on Schizophrenic Patients”

7 trials

Showing 7 of 7 results

Not applicableStudy completedNCT00206960
What this trial is testing

Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia

Who this might be right for
Schizophrenia
Birte Glenthoj 56
Large-scale testing (Phase 3)Ended earlyNCT01363349
What this trial is testing

Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia

Who this might be right for
SchizophreniaCognitive Effect on Schizophrenic Patients
BioLineRx, Ltd. 269
Very early researchStudy completedNCT01186471
What this trial is testing

The Effect of Nicotine on Arousal, Cognition and Social Cognition in Schizophrenic Patients

Who this might be right for
SchizophreniaCognition Disorders
Janssen Pharmaceutica N.V., Belgium 32
Post-approval studies (Phase 4)Study completedNCT00329810
What this trial is testing

Effect on Cognitive Function of a Treatment With Aripiprazole

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 500
Testing effectiveness (Phase 2)Ended earlyNCT00206947
What this trial is testing

The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia

Who this might be right for
Schizophrenia
Birte Glenthoj 50
Early research (Phase 1)Ended earlyNCT01137799
What this trial is testing

The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients

Who this might be right for
SchizophreniaAlzheimer's DiseaseCognition Disorders
Janssen Pharmaceutica N.V., Belgium 47
Not applicableWithdrawnNCT01979796
What this trial is testing

Antismoking Effects of Electronic Cigarettes in Subjects With Schizophrenia and Their Potential Influence on Cognitive Functioning.

Who this might be right for
Tobacco Smoking in Schizophrenic Patients
University of Catania

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation